Literature DB >> 20215868

Mouse neuronal cells expressing exogenous bovine PRNP and simultaneous downregulation of endogenous mouse PRNP using siRNAs.

Sang-Gyun Kang1, Yu Mi Roh, Mi Lan Kang, Yong-Sun Kim, Han Sang Yoo.   

Abstract

Prion diseases, which are called transmissible spongiform encephalopathies (TSEs), comprise a group of fatal infectious neurodegenerative disorders. Investigation of prion strains and generation of species dependent TSE model are necessary to understand pathogenesis of the disease. To establish a BSE-specific in vitro cell culture model, N2a and GT1 mouse neuronal cell lines were generated to express the bovine prion protein by transfection of the bovine prion gene (Prnp). In addition, the endogenous mouse prion protein was suppressed in N2a, NbP, GT1 and GbP cell lines using the siRNA duplexes, siRNA1 and siRNA2 that target the N- and C-termini of murine Prnp, respectively. Both siRNA1 and siRNA2 effectively decreased murine prion protein levels by more than 80% and the downregulation efficacy was increased in siRNA dose-dependent manner. The greatest downregulation was observed 48 h after siRNA delivery. The moPrnp knockdown NbP and GbP cell lines and the Prnp-targeting siRNA technique established in the present study would be useful tools for dissecting the basic mechanisms of prion infection, especially for BSE.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20215868      PMCID: PMC2850418          DOI: 10.4161/pri.4.1.11218

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  30 in total

1.  The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression.

Authors:  L Overbergh; A Giulietti; D Valckx; R Decallonne; R Bouillon; C Mathieu
Journal:  J Biomol Tech       Date:  2003-03

2.  Molecular basis of barriers for interspecies transmissibility of mammalian prions.

Authors:  David L Vanik; Krystyna A Surewicz; Witold K Surewicz
Journal:  Mol Cell       Date:  2004-04-09       Impact factor: 17.970

3.  Generation of monoclonal antibody recognized by the GXXXG motif (glycine zipper) of prion protein.

Authors:  Jin-Kyu Choi; Seok-Ju Park; Yong-Chul Jun; Jae-Min Oh; Byung-Hoon Jeong; Hyun-Pil Lee; Sue-Nie Park; Richard I Carp; Yong-Sun Kim
Journal:  Hybridoma (Larchmt)       Date:  2006-10

4.  Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.

Authors:  Alexander Pfeifer; Sabina Eigenbrod; Saba Al-Khadra; Andreas Hofmann; Gerda Mitteregger; Markus Moser; Uwe Bertsch; Hans Kretzschmar
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

5.  Cell-autonomous PrP-Doppel interaction regulates apoptosis in PrP gene-deficient neuronal cells.

Authors:  Akikazu Sakudo; Deug-chan Lee; Izuru Nakamura; Yojiro Taniuchi; Keiichi Saeki; Yoshitsugu Matsumoto; Shigeyoshi Itohara; Kazuyoshi Ikuta; Takashi Onodera
Journal:  Biochem Biophys Res Commun       Date:  2005-07-29       Impact factor: 3.575

6.  Doppel-induced apoptosis and counteraction by cellular prion protein in neuroblastoma and astrocytes.

Authors:  K Qin; L Zhao; Y Tang; S Bhatta; J M Simard; R Y Zhao
Journal:  Neuroscience       Date:  2006-06-12       Impact factor: 3.590

7.  Specific inhibition of pathological prion protein accumulation by small interfering RNAs.

Authors:  Nathalie Daude; Mathieu Marella; Joelle Chabry
Journal:  J Cell Sci       Date:  2003-05-20       Impact factor: 5.285

8.  siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells.

Authors:  Karin Butz; Tutik Ristriani; Arnd Hengstermann; Claudia Denk; Martin Scheffner; Felix Hoppe-Seyler
Journal:  Oncogene       Date:  2003-09-04       Impact factor: 9.867

Review 9.  Small RNA: can RNA interference be exploited for therapy?

Authors:  Nathan R Wall; Yang Shi
Journal:  Lancet       Date:  2003-10-25       Impact factor: 79.321

10.  Mapping of possible prion protein self-interaction domains using peptide arrays.

Authors:  Alan Rigter; Jan P M Langeveld; Drophatie Timmers-Parohi; Jorg G Jacobs; Peter L J M Moonen; Alex Bossers
Journal:  BMC Biochem       Date:  2007-04-12       Impact factor: 4.059

View more
  3 in total

1.  Establishment and characterization of Prnp knockdown neuroblastoma cells using dual microRNA-mediated RNA interference.

Authors:  Sang-Gyun Kang; Yu-Mi Roh; Agnes Lau; David Westaway; Debbie McKenzie; Judd Aiken; Yong-Sun Kim; Han Sang Yoo
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

2.  Dual MicroRNA to Cellular Prion Protein Inhibits Propagation of Pathogenic Prion Protein in Cultured Cells.

Authors:  Sang-Gyun Kang; Chiye Kim; Judd Aiken; Han Sang Yoo; Debbie McKenzie
Journal:  Mol Neurobiol       Date:  2017-03-29       Impact factor: 5.590

3.  CRISPR-Cas9-based knockout of the prion protein and its effect on the proteome.

Authors:  Mohadeseh Mehrabian; Dylan Brethour; Sarah MacIsaac; Jin Kyu Kim; C Geeth Gunawardana; Hansen Wang; Gerold Schmitt-Ulms
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.